Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
486 total articles
Novanta Inc.'s CEO, Matthijs Glastra, executed a significant stock sale in January 2026, disposing of 7,500 shares at $140 each, amounting to $1.05 million. This transaction occurred as the company's shares demonstrated considerable upward momentum despite trading below their 52-week peak. Concurrently, Novanta revised its earnings forecasts amid a…
On January 23, 2026, Alan H Kumler, serving as Senior Vice President and Chief Accounting Officer at United Community Banks, sold over twelve thousand shares of the bank's common stock valued at approximately $425,800. This transaction took place during a period when the company reported quarterly earnings in line with analyst estimates and surpass…
David R. Bickerton, a board member of Consumers Bancorp Inc, recently enhanced his investment in the company by purchasing 200 shares valued at $5,472. These acquisitions occurred in two transactions on January 23, 2026, at prices slightly above $27 per share. Consumers Bancorp's stock is trending near its highest level in the last year, reflecting…
Iridex Corporation's CFO Romeo R. Dizon recently increased his stake by purchasing 5,221 shares of company stock at an average price of $1.4779, amid a period of strong stock performance and promising preliminary financial results. Despite reporting negative earnings and recent net losses, Iridex shows signs of revenue growth and advancing treatmen…
Beam S Craig, a director at Peoples Bancorp Inc, increased his stake by purchasing 157 shares on January 23, 2026. This insider buying occurred while the bank reported slightly better-than-expected earnings per share but missed revenue projections for the fourth quarter of 2025. Despite these mixed results, Peoples Bancorp continues to offer an att…
On January 22, 2026, Suresh V. Garimella, a director at Modine Manufacturing Co, executed a sale of 1,100 common shares valued at $165,000 under a pre-arranged plan. This transaction occurs in the context of Modine Manufacturing's recent increase in its revolving credit facility and upcoming leadership changes in its Climate Solutions division, alo…
On January 21, 2026, Edgewise Therapeutics' director Badreddin Edris sold over 115,000 shares of the company's stock, raising approximately $3.39 million. This sale was conducted under an established Rule 10b5-1 plan. On the same day, Edris also exercised stock options, acquiring a similar number of shares at much lower prices. These insider activi…
On January 22, 2026, Serina Therapeutics’ Chief Scientific Officer, Randall Moreadith, disposed of 2,500 shares of common stock at $2.95 per share, totaling $7,375. This sale came despite the stock trading lower at $2.72 and a 46.47% decline over six months. Concurrently, Moreadith exercised options for 2,500 shares at a $0.06 exercise price. Serin…
Evans Jae A, a director at Isabella Bank Corp, recently purchased additional shares in the company during a period of notable stock appreciation. Acquired shares were bought through the bank’s deferred compensation plan. Concurrently, Isabella Bank announced the addition of Gerald J. Ritzert as its Chief Financial Officer, underscoring the institut…
David Brian Behen, a director at Isabella Bank Corporation, recently increased his shareholding by acquiring 242.0331 shares valued at $12,000 through the bank's deferred compensation plan. Concurrently, the bank announced the appointment of Gerald J. Ritzert as Chief Financial Officer, bringing over three decades of financial expertise to the inst…
Melinda Marie Coffin, a director at Isabella Bank Corp, executed a purchase of 443.7273 shares on January 20, 2026, investing nearly $22,000 at $49.58 per share. The stock recently traded at $50.34, slightly above her acquisition price. Isabella Bank has delivered an impressive 107% return over the last year and sustains an 18-year streak of divide…
Neil Michael McDonnell, President of Isabella Bank Corp, has increased his stake by acquiring over 300 shares valued at $15,000. This transaction reflects ongoing confidence in the bank, which has delivered a robust 107% stock return over the past year and maintains a solid dividend record. Concurrently, Isabella Bank announced the appointment of G…
Driven Brands Holdings Inc.’s Chief Legal Officer, Scott L. O’Melia, recently sold approximately $750,000 worth of company stock in a transaction aligned with the company’s improving financial outlook. Despite operating at a loss over the past year, Driven Brands shows potential for profitability, backed by positive quarterly earnings and favorable…
Horizon Kinetics Asset Management made a modest acquisition of Texas Pacific Land Corp shares, amidst the company's recent earnings announcement, strategic collaboration with Bolt Data & Energy, and upcoming stock split. Texas Pacific Land's third-quarter financial results slightly missed analyst expectations, while new initiatives signal evolving …
Dwight Eric Smith, serving on the board of Peoples Bancorp Inc, has acquired 500 shares of the company at $32.62 per share. This transaction signals his continued investment confidence as the company trades near his purchase price while maintaining a solid dividend yield and a Good financial health rating. Despite a slight revenue shortfall in the …
Prabir Adarkar, DoorDash's President and COO, sold 11,490 shares valued at over $3 million, while also exercising stock options, reflecting notable insider trading activity. Concurrently, DoorDash is embarking on a major investment cycle and expanding its market strategy with new partnerships and board appointments, as analysts maintain favorable o…
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc., sold 265 shares of the company's stock on January 21, 2026, as part of a pre-arranged plan to offset tax liabilities from vested restricted stock units. Concurrently, Karyopharm reported promising preliminary full-year 2025 financial results, highlighted by $145 million in tot…
Bruce K. Posey, Chief Legal Officer of Qualys, Inc., executed a stock sale totaling $145,708 through multiple transactions on January 20, 2026, under a Rule 10b5-1 plan. Concurrently, Qualys reported notable financial results for Q3, including double-digit revenue growth and high profitability margins, alongside strategic leadership enhancements.
Waystar Holding Corp's Chief Business Officer, Eric L. (Ric) Sinclair III, conducted notable stock transactions on January 20, 2026, involving both sales and option exercises. The company simultaneously announces advancements in its AI-based healthcare payment platform, receiving strong endorsements from multiple financial analysts forecasting grow…
Mentor Capital, Inc.'s CEO Chester Billingsley has recently enhanced his holdings by purchasing 3,800 shares of the company's stock, valued at approximately $335. The acquisitions, executed between January 20 and 22, 2026, raise his direct ownership to over 3.16 million shares. The micro-cap firm, valued at $1.95 million, has experienced a notable …
Morgan Stanley's Chief Financial Officer, Yeshaya Sharon, sold 15,838 shares valued at approximately $2.94 million on January 20, 2026. The transaction took place around the current stock price level amid the company's strong market gains and solid financial results, highlighting ongoing activity within the financial sector.
Andrew Bialecki, serving as director and co-CEO of Klaviyo, executed the sale of 167,826 shares of Series A Common Stock on January 20, 2026, netting approximately $4.1 million. Concurrently, the company reported a strong Black Friday to Cyber Monday sales period and announced the addition of Chano Fernández as co-CEO. These moves occur against a b…
William Lewis, Chair and CEO of Insmed Inc, sold nearly $1.7 million worth of company stock on January 20, 2026, while also exercising options for additional shares. This activity took place amid robust recent sales figures for Insmed’s key drugs Brinsupri and ARIKAYCE, and ahead of an upcoming earnings report.
Tim Truels Hansen, serving as Chief Commercial Officer of Dorian LPG Ltd., recently sold 25,000 shares valued at over $720,000 at a price close to the company's 52-week high. The company, with a strong dividend yield and a solid financial health score, faces challenges as its latest earnings and revenue fell short of analyst expectations, leading t…
Timothy R. Kinser, Vice President of Operations at RPM International, disclosed the sale of 3,441 shares valued at nearly $380,000. This insider action coincides with RPM International's recent financial performance challenges, marked by lowered analyst price targets due to fiscal 2026 earnings and other operational headwinds, despite a steady divi…
